Gmo Benchmark-free Price To Earning vs. Year To Date Return

GBMBX Fund  USD 26.63  0.14  0.52%   
Based on the measurements of profitability obtained from Gmo Benchmark-free's financial statements, Gmo Benchmark Free Allocation may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in December. Profitability indicators assess Gmo Benchmark-free's ability to earn profits and add value for shareholders.
For Gmo Benchmark-free profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Gmo Benchmark-free to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Gmo Benchmark Free Allocation utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Gmo Benchmark-free's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Gmo Benchmark Free Allocation over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis.
Please note, there is a significant difference between Gmo Benchmark-free's value and its price as these two are different measures arrived at by different means. Investors typically determine if Gmo Benchmark-free is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gmo Benchmark-free's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Gmo Benchmark Free Year To Date Return vs. Price To Earning Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Gmo Benchmark-free's current stock value. Our valuation model uses many indicators to compare Gmo Benchmark-free value to that of its competitors to determine the firm's financial worth.
Gmo Benchmark Free Allocation is one of the top funds in price to earning among similar funds. It also is one of the top funds in year to date return among similar funds creating about  0.19  of Year To Date Return per Price To Earning. The ratio of Price To Earning to Year To Date Return for Gmo Benchmark Free Allocation is roughly  5.37 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Gmo Benchmark-free's earnings, one of the primary drivers of an investment's value.

Gmo Year To Date Return vs. Price To Earning

Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

Gmo Benchmark-free

P/E

 = 

Market Value Per Share

Earnings Per Share

 = 
15.62 X
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.

Gmo Benchmark-free

YTD Return

 = 

(Mean of Monthly Returns - 1)

X

100%

 = 
2.91 %
Year-To-Date typically refers to a period starting from the beginning of the current year and continuing up to the present day. Investors should becareful when comparing YTD ratios if not much of the year has occurred as research shows that YTD measures are more sensitive to early periods than late.

Gmo Year To Date Return Comparison

Gmo Benchmark is currently under evaluation in year to date return among similar funds.

Gmo Benchmark-free Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Gmo Benchmark-free, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Gmo Benchmark-free will eventually generate negative long term returns. The profitability progress is the general direction of Gmo Benchmark-free's change in net profit over the period of time. It can combine multiple indicators of Gmo Benchmark-free, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
The fund is structured as a fund of funds and gains its investment exposures primarily by investing in Implementation fund. In addition, the fund may invest in any other GMO fund, whether now existing or created in the future. These underlying GMO Funds may include, among others, Opportunistic Income fund, Emerging Country Debt fund, High Yield fund, and the Alternative funds. The fund is permitted to invest in any asset class, strategy, sector, country, or region, and at times may have substantial exposure to a single asset class, sector, country, region, or currency or companies with similar market capitalizations.

Gmo Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Gmo Benchmark-free. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Gmo Benchmark-free position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Gmo Benchmark-free's important profitability drivers and their relationship over time.

Use Gmo Benchmark-free in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Gmo Benchmark-free position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gmo Benchmark-free will appreciate offsetting losses from the drop in the long position's value.

Gmo Benchmark-free Pair Trading

Gmo Benchmark Free Allocation Pair Trading Analysis

The ability to find closely correlated positions to Gmo Benchmark-free could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Gmo Benchmark-free when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Gmo Benchmark-free - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Gmo Benchmark Free Allocation to buy it.
The correlation of Gmo Benchmark-free is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Gmo Benchmark-free moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Gmo Benchmark Free moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Gmo Benchmark-free can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Gmo Benchmark-free position

In addition to having Gmo Benchmark-free in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Israel Wall Street Thematic Idea Now

Israel Wall Street
Israel Wall Street Theme
Cross-sector collection of best publicly traded Israel entities that are expected to continue growing. The Israel Wall Street theme has 71 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Israel Wall Street Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Gmo Mutual Fund

To fully project Gmo Benchmark-free's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Gmo Benchmark Free at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Gmo Benchmark-free's income statement, its balance sheet, and the statement of cash flows.
Potential Gmo Benchmark-free investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Gmo Benchmark-free investors may work on each financial statement separately, they are all related. The changes in Gmo Benchmark-free's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Gmo Benchmark-free's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities